<DOC>
	<DOCNO>NCT00185705</DOCNO>
	<brief_summary>In study , propose use telmisartan , angiotensin II receptor antagonist PPAR-gamma modulating activity , 12-week period decrease blood pressure insulin level obese , hypertensive child . Telmisartan currently approve treatment adult hypertension . Recent adult study , however , show telmisartan effective medication lower insulin level improve insulin sensitivity . We enroll 30 obese adolescent , age 10 18 year , randomly assign half group receive telmisartan half receive placebo ( sugar-pill ) . We obtain fast glucose insulin level , well marker insulin sensitivity cholesterol panel , begin study , clinic visit 4-week interval , end study . We obtain image study ( compute tomography , CT scan ) 10 randomly select study patient ( 5 group ) examine distribution fat tissue treatment . Studies suggest fat tissue subcutaneous tissue less harmful fat tissue surround internal organ , liver . We also provide nutritional handout exercise recommendation participant life-style intervention . Each participant give diary record diet exercise activity throughout study .</brief_summary>
	<brief_title>Treatment Insulin Resistance Hypertensive , Obese Adolescents</brief_title>
	<detailed_description>Hypothesis : This pilot study provide data essential designing large trial test hypothesis telmisartan treatment obese child insulin resistance hypertension result improve insulin level systolic blood pressure . Secondary outcome measure include effect telmisartan total cholesterol , triglyceride , HDL LDL level , body mass index ( BMI ) , body fat distribution . Specific Aims Test Hypothesis : Aim # 1 : Determine change insulin sensitivity adolescent obesity hyperinsulinemia treatment telmisartan . We hypothesize significant increase insulin sensitivity follow medical treatment . We measure fast insulin glucose level calculation homeostasis model assessment ( HOMA ) [ 29 , 30 ] . Furthermore , calculate parameter insulin production insulin resistance simultaneous measurement glucose , insulin , C-peptide level oral glucose tolerance test ( OGTT ) . We check IGF BP-1 ( insulin-like growth factor 1 binding protein ) level indirect measurement insulin resistance . Due risk associate glucose clamp continuous insulin infusion , use procedure study . Aim # 2 : Determine change systolic blood pressure adolescent obesity hypertension treatment telmisartan . We hypothesize significant decrease systolic blood pressure follow medical treatment . Subjects blood pressure check clinic visit . Aim # 3 : Evaluate change lipid profile body mass index secondary outcome measure telmisartan treatment . Subjects weight , height , fast lipid panel check clinic visit . Aim # 4 : Characterize fat distribution telmisartan treatment . A subset study participant undergo magnetic resonance imaging ( MRI ) characterize separate abdominal adipose tissue subcutaneous visceral component . A one-slice MRI obtain 2 time-points study ( week 0 12 ) . Aim # 5 : Determine feasibility use telmisartan treatment hyperinsulinemia hypertension obese adolescent . Study result provide necessary data calculate power need multi-center , randomize , placebo-controlled trial telmisartan .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Ages 10.00 17.99 year Body mass index ( BMI ) ≥ 95th percentile age gender use CDC data SBP ≥ 95th percentile age , gender , height use fourth report National High Blood Pressure Education Program ( NHBPEP ) guideline . Fasting plasma insulin concentration ≥ 20 U/mL require study entry . This insulin concentration commonly use define insulin resistance . Subjects exclude study know diabetes define American Diabetes Association criterion , prior drug therapy treat diabetes insulin resistance , recent glucocorticoid therapy within 3 month screen visit , current drug therapy treat hypertension , elevate creatinine ( &gt; 1.2mg/dL ) , elevate liver enzyme ( ALT &gt; 80 ) , history current alcohol ingestion , exist pregnancy highrisk become pregnant , serious medical condition investigator determines may put subject undue risk enrol study , take medication potential drugdrug interaction ( anticoagulant , digoxin , diuretic ) .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Insulin resistance</keyword>
	<keyword>obesity</keyword>
	<keyword>hypertension</keyword>
	<keyword>adolescent</keyword>
	<keyword>telmisartan</keyword>
	<keyword>lifestyle intervention</keyword>
</DOC>